ISCHEMIA Trial and the Significance of MI

During the past decade, the treatment of choice for chronic coronary syndromes (CCS) has been a contentious issue. Whether revascularisation, either percutaneous or surgical, or optimal medical therapy, offers better prognosis in terms of mortality, MI, and symptom relief, has yet to be confirmed. T...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Eduardo A Arias, Félix Damas-de los Santos, Heriberto Ontiveros-Mercado
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/27f8c08c55f44a4e92f157da82c56f8d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:27f8c08c55f44a4e92f157da82c56f8d
record_format	dspace
spelling	oai:doaj.org-article:27f8c08c55f44a4e92f157da82c56f8d2021-12-04T16:03:39ZISCHEMIA Trial and the Significance of MI10.15420/icr.2020.151756-14851756-1477https://doaj.org/article/27f8c08c55f44a4e92f157da82c56f8d2020-10-01T00:00:00Zhttps://www.icrjournal.com/articles/ischemia-trial-and-the-significance-of-mihttps://doaj.org/toc/1756-1477https://doaj.org/toc/1756-1485During the past decade, the treatment of choice for chronic coronary syndromes (CCS) has been a contentious issue. Whether revascularisation, either percutaneous or surgical, or optimal medical therapy, offers better prognosis in terms of mortality, MI, and symptom relief, has yet to be confirmed. The long-awaited and recently published International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial randomised more than 5,000 patients into a revascularisation plus optimal medical therapy group and an optimal medical therapy alone group. The authors analyse the trial, with particular emphasis on the incidence of MI. They propose a patient-centred approach to incorporate the results of the ISCHEMIA trial into daily practice and determine the best treatment strategy for patients with CCS.Eduardo A AriasFélix Damas-de los SantosHeriberto Ontiveros-MercadoRadcliffe Medical MediaarticleSurgeryRD1-811Diseases of the circulatory (Cardiovascular) systemRC666-701ENInterventional Cardiology: Reviews, Research, Resources, Vol 15, Iss , Pp - (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701 Eduardo A Arias Félix Damas-de los Santos Heriberto Ontiveros-Mercado ISCHEMIA Trial and the Significance of MI
description	During the past decade, the treatment of choice for chronic coronary syndromes (CCS) has been a contentious issue. Whether revascularisation, either percutaneous or surgical, or optimal medical therapy, offers better prognosis in terms of mortality, MI, and symptom relief, has yet to be confirmed. The long-awaited and recently published International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial randomised more than 5,000 patients into a revascularisation plus optimal medical therapy group and an optimal medical therapy alone group. The authors analyse the trial, with particular emphasis on the incidence of MI. They propose a patient-centred approach to incorporate the results of the ISCHEMIA trial into daily practice and determine the best treatment strategy for patients with CCS.
format	article
author	Eduardo A Arias Félix Damas-de los Santos Heriberto Ontiveros-Mercado
author_facet	Eduardo A Arias Félix Damas-de los Santos Heriberto Ontiveros-Mercado
author_sort	Eduardo A Arias
title	ISCHEMIA Trial and the Significance of MI
title_short	ISCHEMIA Trial and the Significance of MI
title_full	ISCHEMIA Trial and the Significance of MI
title_fullStr	ISCHEMIA Trial and the Significance of MI
title_full_unstemmed	ISCHEMIA Trial and the Significance of MI
title_sort	ischemia trial and the significance of mi
publisher	Radcliffe Medical Media
publishDate	2020
url	https://doaj.org/article/27f8c08c55f44a4e92f157da82c56f8d
work_keys_str_mv	AT eduardoaarias ischemiatrialandthesignificanceofmi AT felixdamasdelossantos ischemiatrialandthesignificanceofmi AT heribertoontiverosmercado ischemiatrialandthesignificanceofmi
_version_	1718372723169689600

ISCHEMIA Trial and the Significance of MI

Ejemplares similares